BGLC VS OSA Stock Comparison

PerformanceProfitVolatilityTechnicalsEarnings
PerformanceProfitVolatilityTechnicalsEarnings

Performance

BGLC
10/100

BGLC returned -97.12% in the last 12 months. Based on SPY's performance of -13.73%, its performance is below average giving it a score of 10 of 100.

OSA
10/100

OSA returned -95.30% in the last 12 months. Based on SPY's performance of -13.41%, its performance is below average giving it a score of 10 of 100.

Profit

BGLC
33/100

Out of the last 18 quarters, BGLC has had 6 profitable quarters and has increased their profits year over year on 4 of them.

OSA
36/100

Out of the last 11 quarters, OSA has had 2 profitable quarters and has increased their profits year over year on 3 of them.

Volatility

BGLC
56/100

BGLC has had a higher than average amount of volatility over the last 12 months giving it a score of 56 of 100.

OSA
21/100

OSA has had a lower than average amount of volatility over the last 12 months giving it a score of 21 of 100.

Technicals

BGLC

"Technicals" not found for BGLC

OSA
14/100

OSA receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

Earnings

BGLC

"Earnings" not found for BGLC

OSA
14/100

OSA has missed earnings 3 times in the last 20 quarters.

All score calculations are broken down here to help you make more informed investing decisions

BioNexus Gene Lab Corp Common stock Summary

Nasdaq / BGLC
Healthcare
Medical - Diagnostics & Research
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

ProSomnus, Inc. Common Stock Summary

Nasdaq / OSA
Healthcare
Medical - Devices
Prosomnus Sleep Technologies, Inc. designs, manufactures, and markets sleep apnea therapy devices for dentists to treat patients diagnosed with obstructive sleep apnea. The company was incorporated in 2016 and is based in Pleasanton, California.